© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 10, 830-832,
May 19, 1999
© 1999 Oxford University Press
NEWS |
Awards, Appointments, Announcements
The National Science Board, governing body of the National Science Foundation, named Maxine Frank Singer, Ph.D., as recipient of the 1999 Vannevar Bush Award to recognize "her many years of scientific achievements in molecular biology."Singer is president of the Carnegie Institute of Washington, D.C. She was also cited for her "activism and creativity in developing programs in math and science education for inner-city Washington, D.C., school children and their teachers," and for "influencing national science policy, particularly where there are social, moral, or ethical implications."
AACR Honors Seven
At its recent annual meeting in Philadelphia, the American Association for Cancer Research presented seven cancer investigators with its annual research awards and lectureships.
Mina J. Bissell, Ph.D., director of the Life Sciences Division of the Lawrence Berkeley National Laboratory at the University of California, received the 1999 Clowes award.
Dennis J. Slamon, M.D., Ph.D., director of the Revlon/UCLA Women's Cancer Research Program, Los Angeles, received the Richard and Hinda Rosenthal Foundation Award.
John Kuriyan, Ph.D., Howard Hughes Medical Institute investigator and professor at Rockefeller University, New York, received the Cornelius P. Rhoads Memorial Award.
J. Martin Brown, D.Phil., professor and director of the Division of Radiation Biology and director of the Program in Cancer Biology at Stanford University, Palo Alto, Calif., received the Bruce F. Cain Memorial Award.
Alice S. Whittemore, Ph.D, professor and chief of the Division of Epidemiology at the Northern California Cancer Center, Union City, Calif., received the AACR/American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention.
|
John Mendelsohn, M.D., president of the University of Texas M. D. Anderson Cancer Center, Houston, received the Joseph H. Burchenal Clinical Research Award.
Bandaru S. Reddy, D.V.M., Ph.D., chief of the Division of Nutritional Carcinogenesis at the American Health Foundation, New York, received the DeWitt S. Goodman Lectureship
Lichter Named Dean
The University of Michigan, Ann Arbor, announced that Allen S. Lichter, M.D., was named by the university's Board of Regents as the Medical School's 14th dean, effective May 1.
|
Lichter, who is president of the American Society of Clinical Oncology, is professor of radiation oncology and served for 4 months as interim dean of the Medical School.
ASBMT Installs Officers
The American Society for Blood and Marrow Transplantation, Arlington Heights, Ill., installed Allen C. Eaves, M.D., Ph.D., as its new president. Eaves is professor and head of the Division of Hematology at the University of British Columbia, Vancouver.
Richard O'Reilly, M.D., chair of pediatrics and chief of the Bone Marrow Transplantation Service at Memorial Sloan-Kettering Cancer Center, New York, is the new vice president and will become president in 2001.
Armand Keating, M.D., of the University of Toronto, and John Wingard, M.D., of the University of Florida, Gainesville, were re-elected to 3-year terms on the board.
New AACR Officers Elected
The American Association for Cancer Research announced that Daniel D. Von Hoff, M.D., of the Cancer Research and Therapy Center, San Antonio, became president of the association during its recent annual meeting.
He succeeds Webster K. Cavenee, Ph.D., who became past president. Cavenee is director of the Ludwig Institute for Cancer Research, San Diego.
The new president-elect is Tom Curran, Ph.D., chairman of Developmental Neurobiology at St. Jude Children's Research Hospital and professor at the University of Tennessee, Memphis.
Rowland Heads NCI Office
At the National Cancer Institute, Julia Howe Rowland, Ph.D., was named director of the Office of Cancer Survivorship in the Division of Cancer Control and Population Sciences. The office's focus is on research in the field of cancer survivorship. She succeeds Anna Meadows, M.D., who founded the office.
Rowland goes to NCI from the Georgetown University School of Medicine, Washington, D.C., where she was associate professor of psychology.
Nixon Joins AHF
The new president of the American Health Foundation, New York, is Daniel Nixon, M.D. He succeeds Ernst L. Wynder, M.D., who founded AHF in 1969 and has led it ever since. Wynder becomes president emeritus.
|
Nixon had been on the faculty of the Medical University of South Carolina College of Medicine, Charleston.
Wynder is one of the pioneers who established a link between smoking and cancer in the early 1950s. Later, he established the American Health Foundation with the mission of reducing the incidence of avoidable chronic disease through preventive medicine.
The work of the foundation, he said, is based on three truths: "First, most major diseases . . . are avoidable. Second, their onset is generally due to lifestyle choices. . . . Third, through the practice of preventive medicine, we can translate this knowledge into better health for all."
RPCI Names Buczkowski
The Roswell Park Cancer Institute, Buffalo, N.Y., named Lisa M. Buczkowski as its financial administrator of managed care.
|
Buczkowski had been director of operations at North American Health Care, also in Buffalo, where she oversaw managed care administration of a health maintenance organization with 200,000 members.
Gift to City of Hope
The City of Hope National Medical Center and Beckman Research Institute, Los Angeles, announced that it received the largest individual gift in its history — $36 million — from Irwin Helford, chairman of Viking Office Products and vice chairman of Office Depot.
The funds will be used to begin construction of a 144-bed hospital facility that will also support clinical research. The facility will be named the Betty & Irwin Helford Clinical Research Hospital when it opens in 2004.
Arizona Names Von Hoff
The Arizona Cancer Center, Tucson, announced that Daniel D. Von Hoff, M.D., will become its second director, effective in mid-August, succeeding founding director Sydney E. Salmon, M.D.
|
|
Von Hoff is director of the Institute for Drug Development at the Cancer Therapy and Research Center, San Antonio, and professor of medical oncology at the University of Texas Health Science Center in San Antonio. In addition, he is the new president of the American Association for Cancer Research.
Salmon requested last summer that a search be conducted for a successor and that when that individual was in place he would step down, but remain as the center's director emeritus and continue to be active in teaching and research as Regents Professor of Medicine.
UPCI Names Medical Director
The University of Pittsburgh Cancer Institute announced that Steven Savona, M.D., will be the medical director of its facility at an institution called UPMC St. Margaret.
Since November, he has been associate clinical professor of medicine at the University of Pittsburgh School of Medicine. Earlier he was associate clinical professor of medicine at New York Medical College.
PharmaNet Appoints Three
PharmaNet, Princeton, N.J., recently announced the addition of three staff members in its Oncology Division. The company is a contract organization providing clinical trials services to pharmaceutical and biotechnology companies.
James O'Brien, M.D., who comes to the company from Memorial Sloan-Kettering Cancer Center, New York, is the director of oncology, medical, and scientific affairs.
Dalvir Gill, Ph.D., is senior director of clinical oncology research. He had been with Rhône-Poulenc Rorer where he was clinical operations leader for the regulatory filing of its drug, Taxotere.
Pablo Fernandez, L.M.S., is vice president for clinical research and head of the company's European clinical research team. Earlier he has been with American Cyanamid, Wyeth-Ayerst, the Wellcome Foundation, and Bayer.
Bristol Award to Texas
The Bristol-Myers Squibb Foundation, New York, recently presented a $500,000 unrestricted cancer research grant to the Nancy B. & Jake L. Hamon Center for Therapeutic Oncology Research at the University of Texas Southwestern Medical Center, Dallas. The funds are to support the center's work "in identifying genetic changes leading to lung and breast cancer."
John Minna, M.D., director of both the Hamon center and the "Tex" & Deborah Moncrief, Jr., Center for Cancer Genetics at Southwestern, will oversee the grant.
Bristol-Myers Squibb's Unrestricted Cancer Grants Program is one of six such programs it sponsors. Others are in the areas of cardiovascular/metabolic disorders, infectious diseases, the neurosciences, nutrition, and orthopedics.
Since the program was initiated in 1977, the six programs committed more than $80 million to unrestricted biomedical research in more than 165 institutions in 21 countries, including more than $23 million to cancer research.
Clarification
The University of Miami's Sylvester Comprehensive Cancer Center issued a clarification of the position of a new member of its staff, Kapil N. Bhalla, M.D. Bhalla is director of the center's clinical and translational research team.
Erratum
In the April 21 News, in the Stat Bite on recent U.S. cancer rates by race and ethnicity (p. 672) labeling for incidence (left graph) and mortality (right graph) were inadvertently omitted. The Stat Bite also did not indicate that the presented data were rates per 100,000 population.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||